NORD Launches Education Series to Advance Patient Involvement in Rare Disease Drug Development
October 17, 2023
October 17, 2023
DANBURY, Connecticut, Oct. 17 (TNSres) -- The National Organization for Rare Disorders issued the following news release on Oct. 16, 2023:
Today, the National Organization for Rare Disorders (NORD) launched a new education series in English and Spanish titled, "Rare Disease Drug Development: What Patients and Advocates Need to Know," designed to help patients and patient advocacy groups understand the drug development process.
"The goal of this educationa . . .
Today, the National Organization for Rare Disorders (NORD) launched a new education series in English and Spanish titled, "Rare Disease Drug Development: What Patients and Advocates Need to Know," designed to help patients and patient advocacy groups understand the drug development process.
"The goal of this educationa . . .